EP2278960
Tilhögun á lyfjagjöf fyrir valvísan SIP1 viðtakaörva
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.3.2009EP published:
30.11.2016EP application number:
09721703.8
EP translation filed:
9.1.2017Grant published:
15.2.2017EPO information:
European Patent Register
Max expiry date:
11.3.2029Expiry date:
11.3.2024
Title:
DOSING REGIMEN FOR A SELECTIVE SIP1 RECEPTOR AGONIST
Timeline
Today
12.3.2009EP application
30.11.2016EP Publication
9.1.2017Translation submitted
15.2.2017Registration published
11.3.2024Expires
Owner
Name:
Actelion Pharmaceuticals Ltd.Address:
Gewerbestrasse 16, 4123, Allschwil, CH
Inventor
Name:
BROSSARD, PatrickAddress:
Allschwil, CH
Name:
DINGEMANSE, JasperAddress:
Allschwil, CH
Name:
NAYLER, OliverAddress:
Arlesheim, CH
Name:
SCHERZ, MichaelAddress:
Ettingen, CH
Name:
STEINER, BeatAddress:
Dornach, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/IB2008/050995Date:
17.3.2008Country:
WO
Classification
Categories:
A61K 31/00, A61K 31/426, A61P 9/06
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 16.2.2017
Expires: 11.3.2018
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 20.2.2018
Expires: 11.3.2019
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 7.2.2019
Expires: 11.3.2020
Payer: Árnason Faktor
Number: 12
Paid: 18.2.2020
Expires: 11.3.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.2.2021
Expires: 11.3.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.2.2022
Expires: 11.3.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.2.2023
Expires: 11.3.2024
Payer: Árnason Faktor ehf.